SHORT OVERVIEW OF CLINICAL TRIALS WITH CURRENT IMMUNOTHERAPEUTIC TOOLS FOR CANCER TREATMENT
Over last decade, a substantial progress has been made, with respect to understanding of cancer biology and its interplay with the host immune system. Different immunotherapeutic drugs based on recombinant cytokines and monoclonal antibodies are widely used in cancer therapy, and a large number of e...
Guardado en:
Autores principales: | T. S. Nepomnyashchikh, D. V. Antonets, R. A. Maksyutov |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2b2e74cb209d4fa0b24f5f2f85dca31b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Obtainingvaccinia virus with increased production of extracellular enveloped virions and directing GM-CSF synthesis as a promising basis for development of antitumor drug
por: T. V. Bauer, et al.
Publicado: (2020) -
Viruses as nanomedicine for cancer
por: Badrinath N, et al.
Publicado: (2016) -
The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors
por: Kyle M. Pierce, et al.
Publicado: (2021) -
SELECTED ASPECTS OF ALLO- AND XENOGRAFT MODEL APPLICATIONS FOR DEVELOPING NOVEL ANTI-CANCER VACCINES AND ONCOLYTIC VIRUSES
por: T. S. Nepomnyashchikh, et al.
Publicado: (2019) -
Spinoculation and retronectin highly enhance the gene transduction efficiency of Mucin-1-specific chimeric antigen receptor (CAR) in human primary T cells
por: Alireza Rajabzadeh, et al.
Publicado: (2021)